Risk of connective tissue disorders among breast implant patients

American Journal of Epidemiology

Volumn 160, Issue 7, 2004, Pages 619-627

  Brinton, Louise A ^a   Buckley, Lenore M ^b   Dvorkina, Olga ^c   Lubin, Jay H ^a   Colton, Theodore ^d   Murray, Mary Cay ^e   Hoover, Robert N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d BOSTON UNIVERSITY   (United States)

^e ABT ASSOCIATES   (United States)

Author keywords

Arthritis, rheumatoid; Breast implants; Connective tissue diseases; Risk; Scleroderma, systemic; Sj gren's syndrome

Indexed keywords

MORBIDITY; RISK FACTOR;

ADULT; ARTHRITIS; ARTICLE; BREAST ENDOPROSTHESIS; CHRONIC FATIGUE SYNDROME; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONNECTIVE TISSUE DISEASE; FEMALE; FIBROMYALGIA; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PLASTIC SURGERY; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SCLERODERMA; SELF REPORT; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES; VASCULITIS;

ADULT; BREAST IMPLANTS; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; SURGERY, PLASTIC; TRUTH DISCLOSURE;

EID: 4644268789     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh272     Document Type: Article

References (58)

1. Brinton LA, Lubin JH, Burich MC, et al. Breast cancer following augmentation mammoplasty (United States). Cancer Causes Control 2000;11:819-27.
2. Brinton LA, Lubin JH, Burich MC, et al. Cancer risk at sites other than the breast following augmentation mammoplasty. Ann Epidemiol 2001;11:248-56.
3. McLaughlin JK, Nyren O, Blot WJ, et al. Cancer risk among women with cosmetic breast implants: a population-based cohort study in Sweden. J Natl Cancer Inst 1998;90:156-8.
4. Mellemkjaer L, Kjoller K, Friis S, et al. Cancer occurrence after cosmetic breast implantation in Denmark. Int J Cancer 2000;88:301-6.
5. Baldwin CM Jr, Kaplan EN. Silicone-induced human adjuvant disease? Ann Plast Surg 1983;10:270-3.
6. Copeland M, Kressel A, Spiera H, et al. Systemic inflammatory disorder related to fibrous breast capsules after silicone implant removal. Plast Reconstr Surg 1993;92:1179-81.
7. Fock KM, Feng PH, Tey BH. Autoimmune disease developing after augmentation mammoplasty: report of 3 cases. J Rheumatol 1984;11:98-100.
8. Marik PE, Kark AL, Zambakides A. Scleroderma after silicone augmentation mammoplasty: a report of 2 cases. S Afr Med J 1990;77:212-13.
9. Okano Y, Nishikai M, Sato A. Scleroderma, primary biliary cirrhosis, and Sjögren's syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease. Ann Rheum Dis 1984;43:520-2.
10. Sahn EE, Garen PD, Silver RM, et al. Scleroderma following augmentation mammoplasty: report of a case and review of the literature. Arch Dermatol 1990;126:1198-202.
11. Sergott TJ, Limoli JP, Baldwin CM Jr, et al. Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plast Reconstr Surg 1986;78:104-14.
12. Spiera H, Kerr LD. Scleroderma following silicone implantation: a cumulative experience of 11 cases. J Rheumatol 1993;20:958-61.
13. van Nunen SA, Gatenby PA, Basten A. Post-mammoplasty connective tissue disease. Arthritis Rheum 1982;25:694-7.
14. Varga J, Schumacher HR, Jimenez SA. Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med 1989;111:377-83.
15. Weiner SR, Paulus HE. Chronic arthropathy occurring after augmentation mammoplasty. Plast Reconstr Surg 1986;77:185-92.
16. Burns CJ, Laing TJ, Gillespie BW, et al. The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol 1996;23:1904-11.
17. Edworthy SM, Martin L, Barr SG, et al. A clinical study of the relationship between silicone breast implants and connective tissue disease. J Rheumatol 1998;25:254-60.
18. Englert H, Joyner E, McGill N, et al. Women's health after plastic surgery. Intern Med J 2001;31:77-89.
19. Gabriel SE, O'Fallon WM, Kurland LT, et al. Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 1994;330:1697-702.
20. Giltay EJ, Bernelot Moens HJ, Riley AH, et al. Silicone breast prostheses and rheumatic symptoms: a retrospective follow up study. Ann Rheum Dis 1994;53:194-6.
21. Goldman JA, Greenblatt J, Joines R, et al. Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice. J Clin Epidemiol 1995;48:571-82.
22. Greenland S, Finkle WD. A retrospective cohort study of implanted medical devices and selected chronic diseases in Medicare claims data. Ann Epidemiol 2000;10:205-13.
23. Hennekens CH, Lee IM, Cook NR, et al. Self-reported breast implants and connective-tissue diseases in female health professionals: a retrospective cohort study. JAMA 1996;275:616-21.
24. Hochberg MC, Perlmutter DL, Medsger TA Jr, et al. Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis Rheum 1996;39:1125-31.
25. Kjoller K, Friis S, Mellemkjaer L, et al. Connective tissue disease and other rheumatic conditions following cosmetic breast implantation in Denmark. Arch Intern Med 2001;161:973-9.
26. Lai S, Goldman JA, Child AH, et al. Fibromyalgia, hypermobility, and breast implants. J Rheumatol 2000;27:2237-41.
27. Nyren O, Yin L, Josefsson S, et al. Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ 1998;316:417-22.
28. Park AJ, Black RJ, Sarhadi NS, et al. Silicone gel-filled breast implants and connective tissue diseases. Plast Reconstr Surg 1998;101:261-8.
29. Sanchez-Guerrero J, Colditz GA, Karlson EW, et al. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med 1995;332:1666-70.
30. Schusterman MA, Kroll SS, Reece GP, et al. Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue: a preliminary report. Ann Plast Surg 1993;31:1-6.
31. Strom BL, Reidenberg MM, Freundlich B, et al. Breast silicone implants and risk of systemic lupus erythematosus. J Clin Epidemiol 1994;47:1211-14.
32. Weisman MH, Vecchione TR, Albert D, et al. Connective-tissue disease following breast augmentation: a preliminary test of the human adjuvant disease hypothesis. Plast Reconstr Surg 1988;82:626-30.
33. Wells KE, Cruse CW, Baker JL Jr, et al. The health status of women following cosmetic surgery. Plast Reconstr Surg 1994;93:907-12.
34. Williams HJ, Weisman MH, Berry CC. Breast implants in patients with differentiated and undifferentiated connective tissue disease. Arthritis Rheum 1997;40:437-40.
35. Wolfe F, Anderson J. Silicone filled breast implants and the risk of flbromyalgia and rheumatoid arthritis. J Rheumatol 1999;26:2025-8.
36. Brinton LA, Lubin JH, Burich MC, et al. Mortality among augmentation mammoplasty patients. Epidemiology 2001;12:321-6.
37. Breslow NE, Day NE, eds. Statistical methods in cancer research. Vol 2. The design and analysis of cohort studies. (IARC Scientific Publication no. 82). Lyon, France: International Agency for Research on Cancer, 1987.
38. Preston DL, Lubin JH, Pierce DA, et al. EPICURE: risk regression and data analysis software. Seattle, WA: HiroSoft International Corporation, 1996.
39. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
40. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
41. Brown SL, Pennello G, Berg WA, et al. Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women. J Rheumatol 2001;28:996-1003.
42. Karlson EW, Lee IM, Cook NR, et al. Comparison of self-reported diagnosis of connective tissue disease with medical records in female health professionals: The Women's Health Cohort Study. Am J Epidemiol 1999;150:652-60.
43. Brinton LA, Brown SL, Colton T, et al. Characteristics of a population of women with breast implants compared with women seeking other types of plastic surgery. Plast Reconstr Surg 2000;105:919-27.
44. Dugowson CE, Daling J, Koepsell TD, et al. Silicone breast implants and risk for rheumatoid arthritis. (Abstract). Arthritis Rheum 1992;35(suppl):S66.
45. Michet CJ Jr, McKenna CH, Elveback LR, et al. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105-13.
46. Englert H, Morris D, March L. Scleroderma and silicone gel breast prostheses - the Sydney study revisited. Aust N Z J Med 1996;26:349-55.
47. Pillemer SR, Matteson EL, Jacobsson LT, et al. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 2001;76:593-9.
48. Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 2000;342:781-90.
49. Borenstein D. Siliconosis: a spectrum of illness. Semin Arthritis Rheum 1994;24(suppl 1):1-7.
50. Solomon G. A clinical and laboratory profile of symptomatic women with silicone breast implants. Semin Arthritis Rheum 1994;24(suppl 1):29-37.
51. Vasey FB, Havice DL, Bocanegra TS, et al. Clinical findings in symptomatic women with silicone breast implants. Semin Arthritis Rheum 1994;24(suppl 1):22-8.
52. De Becker P, McGregor N, De Meirleir K. A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome. J Intern Med 2001;250:234-40.
53. Cuellar ML, Gluck O, Molina JF, et al. Silicone breast implant-associated musculoskeletal manifestations. Clin Rheumatol 1995;14:667-72.
54. Lu LB, Shoaib BO, Patten BM. Atypical chest pain syndrome in patients with breast implants. South Med J 1994;87:978-84.
55. Shoaib BO, Patten BM, Calkins DS. Adjuvant breast disease: an evaluation of 100 symptomatic women with breast implants or silicone fluid injections. Keio J Med 1994;43:79-87.
56. Laing TJ, Schottenfeld D, Lacey JV Jr, et al. Potential risk factors for undifferentiated connective tissue disease among women: implanted medical devices. Am J Epidemiol 2001;154:610-17.
57. Fryzek JP, Signorello LB, Hakelius L, et al. Self-reported symptoms among women after cosmetic breast implant and breast reduction surgery. Plast Reconstr Surg 2001;107:206-13.
58. Jensen B, Bliddal H, Kjoller K, et al. Rheumatic manifestations in Danish women with silicone breast implants. Clin Rheumatol 2001;20:345-52.